All Pharma News
Celltrion showcases promising results in phase III study for CT-P47

Celltrion showcases promising results in phase III study for CT-P47
BUSINESSWIRE
13 Jun 2024
Share Share
Celltrion Healthcare`s Omlyclo (omalizumab) Receives Approval in the Europe

Celltrion Healthcare`s Omlyclo (omalizumab) Receives Approval in the Europe
EMA
29 May 2024
Share Share
EC approves Celltrion’s Omlyclo for allergic conditions

EC approves Celltrion’s Omlyclo for allergic conditions
PHARMACEUTICAL TECHNOLOGY
24 May 2024
Share Share
Celltrion Omlyclo® Ec Approval: First Omalizumab Biosimilar In Europe

Celltrion Omlyclo® Ec Approval: First Omalizumab Biosimilar In Europe
BUSINESSWIRE
23 May 2024
Share Share
ZYMFENTRA Demonstrates 2-Year Crohn`s, UC Efficacy, Safety Profile

ZYMFENTRA Demonstrates 2-Year Crohn`s, UC Efficacy, Safety Profile
PR NEWSWIRE
21 May 2024
Share Share
Reality TV star, Mollie Pearce, backs campaign to tackle in condition

Reality TV star, Mollie Pearce, backs campaign to tackle in condition
PHARMIWEB
20 May 2024
Share Share
Reality Star Backs Campaign On Condition Impacting Millions

Reality Star Backs Campaign On Condition Impacting Millions
BUSINESSWIRE
18 May 2024
Share Share
Celltrion HUMIRA Biosimilar At Low Wholesale Acquisition Cost

Celltrion HUMIRA Biosimilar At Low Wholesale Acquisition Cost
PR NEWSWIRE
09 May 2024
Share Share
Celltrion USA, Express Scripts Deal For ZYMFENTRA™ & Autoimmune Therapies

Celltrion USA, Express Scripts Deal For ZYMFENTRA™ & Autoimmune Therapies
PR NEWSWIRE
28 Apr 2024
Share Share
Celltrion USA completes submission of BLA to U.S. FDA for CT-P39

Celltrion USA completes submission of BLA to U.S. FDA for CT-P39
PR NEWSWIRE
10 Mar 2024
Share Share